Cargando…
Current practice for diagnosing immediate drug hypersensitivity reactions in Korea
BACKGROUND/AIMS: Skin (STs) and drug provocation (DPTs) tests are essential for identifying the culprit drugs causing drug hypersensitivity reactions (DHRs). Several protocols have been developed for the identification of some culprit drugs, but they are neither thoroughly validated nor standardized...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Association of Internal Medicine
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8009158/ https://www.ncbi.nlm.nih.gov/pubmed/33401343 http://dx.doi.org/10.3904/kjim.2020.143 |
_version_ | 1783672825798721536 |
---|---|
author | Kang, Sung-Yoon Yang, Min-Suk Song, Woo-Jung Cho, Sang-Heon |
author_facet | Kang, Sung-Yoon Yang, Min-Suk Song, Woo-Jung Cho, Sang-Heon |
author_sort | Kang, Sung-Yoon |
collection | PubMed |
description | BACKGROUND/AIMS: Skin (STs) and drug provocation (DPTs) tests are essential for identifying the culprit drugs causing drug hypersensitivity reactions (DHRs). Several protocols have been developed for the identification of some culprit drugs, but they are neither thoroughly validated nor standardized. Furthermore, language barriers may impede the exchange of information necessary for test standardization. METHODS: We searched the Korean literature for articles on drug hypersensitivity published from 1933 to 2016 using the KoreaMed search engine and archives of Korean journals. We reviewed and rated all articles according to the description of STs and DPTs. RESULTS: Of the 632 articles obtained in our initial search, 34 had adequate descriptions of 15 STs and 22 DPTs. Up to 27 healthy control subjects in STs were enrolled to determine non-irritating concentrations. The concentrations used for intradermal tests were commonly a 1/10 dilution of those used for skin prick tests. The interpretations of the STs were mostly similar among researchers. For DPTs, most procedures were single-arm open-label tests of various drugs. The initial dose ranged from a quarter dose to a single therapeutic dose, depending on the severity of the original hypersensitivity reaction. The interval between doses was usually 30 to 60 minutes, and a positive reaction usually occurred within twice the time of the original reaction. CONCLUSIONS: Efforts to distribute information are necessary to standardize protocols and better understand DHRs. |
format | Online Article Text |
id | pubmed-8009158 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | The Korean Association of Internal Medicine |
record_format | MEDLINE/PubMed |
spelling | pubmed-80091582021-04-02 Current practice for diagnosing immediate drug hypersensitivity reactions in Korea Kang, Sung-Yoon Yang, Min-Suk Song, Woo-Jung Cho, Sang-Heon Korean J Intern Med Original Article BACKGROUND/AIMS: Skin (STs) and drug provocation (DPTs) tests are essential for identifying the culprit drugs causing drug hypersensitivity reactions (DHRs). Several protocols have been developed for the identification of some culprit drugs, but they are neither thoroughly validated nor standardized. Furthermore, language barriers may impede the exchange of information necessary for test standardization. METHODS: We searched the Korean literature for articles on drug hypersensitivity published from 1933 to 2016 using the KoreaMed search engine and archives of Korean journals. We reviewed and rated all articles according to the description of STs and DPTs. RESULTS: Of the 632 articles obtained in our initial search, 34 had adequate descriptions of 15 STs and 22 DPTs. Up to 27 healthy control subjects in STs were enrolled to determine non-irritating concentrations. The concentrations used for intradermal tests were commonly a 1/10 dilution of those used for skin prick tests. The interpretations of the STs were mostly similar among researchers. For DPTs, most procedures were single-arm open-label tests of various drugs. The initial dose ranged from a quarter dose to a single therapeutic dose, depending on the severity of the original hypersensitivity reaction. The interval between doses was usually 30 to 60 minutes, and a positive reaction usually occurred within twice the time of the original reaction. CONCLUSIONS: Efforts to distribute information are necessary to standardize protocols and better understand DHRs. The Korean Association of Internal Medicine 2021-03 2021-01-05 /pmc/articles/PMC8009158/ /pubmed/33401343 http://dx.doi.org/10.3904/kjim.2020.143 Text en Copyright © 2021 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Kang, Sung-Yoon Yang, Min-Suk Song, Woo-Jung Cho, Sang-Heon Current practice for diagnosing immediate drug hypersensitivity reactions in Korea |
title | Current practice for diagnosing immediate drug hypersensitivity reactions in Korea |
title_full | Current practice for diagnosing immediate drug hypersensitivity reactions in Korea |
title_fullStr | Current practice for diagnosing immediate drug hypersensitivity reactions in Korea |
title_full_unstemmed | Current practice for diagnosing immediate drug hypersensitivity reactions in Korea |
title_short | Current practice for diagnosing immediate drug hypersensitivity reactions in Korea |
title_sort | current practice for diagnosing immediate drug hypersensitivity reactions in korea |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8009158/ https://www.ncbi.nlm.nih.gov/pubmed/33401343 http://dx.doi.org/10.3904/kjim.2020.143 |
work_keys_str_mv | AT kangsungyoon currentpracticefordiagnosingimmediatedrughypersensitivityreactionsinkorea AT yangminsuk currentpracticefordiagnosingimmediatedrughypersensitivityreactionsinkorea AT songwoojung currentpracticefordiagnosingimmediatedrughypersensitivityreactionsinkorea AT chosangheon currentpracticefordiagnosingimmediatedrughypersensitivityreactionsinkorea |